Condition: Hepatoblastoma · Sponsor: Shanghai Children's Medical Center
A Phase 3 multi-institutional study for treatment of children with newly diagnosed hepatoblastoma using a modified Paediatric Hepatic International Tumour Trial (PHITT) strategy incorporating a randomized assessment of sodium thiosulfate as auditory protection for children with localized disease, and response adapted therapy for patients with metastatic disease
This description comes directly from the study's public registry record.
Haishan Ruan, MS · +8618801902467 · ruanhaishan@scmc.com.cn
Yujia Tang, MD · +8618516342079 · tangyuejia@scmc.com.cn
Always discuss trial participation with your own doctor first.
| Shanghai Children's Medical Center | Shanghai, Shanghai Municipality, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04478292